Global Health Initiative
The AUTM Global Health Toolkit
The AUTM Global Health Toolkit includes AUTM position documents as well as relevant papers and articles on global health issues.
Case Studies for Global Health
The Bill & Melinda Gates Foundation, Biotechnology Industry Organization (BIO), Global Health Progress (GHP), International AIDS Vaccine Initiative (IAVI), Infectious Disease Research Institute (IDRI), Association of University Technology Managers (AUTM) and World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR), have joined together to prepare a set of multi-sector case studies to identify ways in which key stakeholders are addressing global health concerns.
Case Studies for Global Health examines and illustrate how people, organizations, companies and governments have worked together to try to solve a global health challenge. The wide range of topics include the complexity of intellectual property, length and stage of product development, costs and nature of manufacturing, purchasers and markets, financing mechanisms, regulatory issues, capacity building, delivery mechanisms and adoption hurdles.
The Better World Project
The Better World Project is an AUTM initiative to highlight the positive impact of academic innovations on society. Each year AUTM publishes a report that includes the surprising and inspiring stories behind innovations that have changed the way we live.
The theme for the 2009 edition of the AUTM Better World Report focuses on Global Heath and the role technology transfer plays in the lives and well being of people everywhere. To read these stories, download the 2009 AUTM Better World Report (PDF File 4.25 MB).
The Nine Points to Consider in Licensing University Technology
There is increasing awareness that responsible licensing includes consideration of the needs of people in developing countries and members of other underserved populations. In The Nine Points to Consider in Licensing University Technology, the issue of global health is specifically addressed in Point 9, "Consider including provisions that address unmet needs, such as those of neglected patient populations or geographic areas, giving particular attention to improved therapeutics, diagnostics and agricultural technologies for the developing world."